The UK licensing position for under-18s
According to the Medicines and Healthcare products Regulatory Agency (MHRA) and the British National Formulary for Children (BNFC):
- Neuropathic Pain: Not licensed. Children experiencing neuropathic pain (e.g. following spinal surgery or oncology treatments) are managed through specialized paediatric chronic pain services using alternative clinical pathways.
- Generalised Anxiety Disorder: Not licensed. Paediatric anxiety must be treated via Child and Adolescent Mental Health Services (CAMHS) using psychological therapies (CBT) and licensed medications (such as fluoxetine) where indicated.
- Epilepsy: Not licensed for general use in children, though specialized tertiary neurological use occurs off-label.
Why is Pregabalin not licensed for children?
Paediatric clinical trials evaluating gabapentinoids in children faced significant challenges:
- Lack of demonstrated superiority: Several paediatric clinical trials in childhood epilepsy and pain failed to demonstrate a statistically significant benefit over placebo.
- Developing brain vulnerability: The developing central nervous system is undergoing rapid synaptic pruning and myelination. Chronic dampening of voltage-gated calcium channels raises theoretical concerns regarding long-term learning, memory formation, and executive cognitive functioning.
- Higher incidence of behavioural side effects: Paediatric patients in clinical studies experienced higher rates of emotional lability, aggressive outbursts, hyperactivity, and paradoxical agitation compared to adults.
Specialist off-label paediatric use in epilepsy
In tertiary children’s hospitals (such as Great Ormond Street Hospital or Alder Hey Children's NHS Foundation Trust), a consultant paediatric neurologist may occasionally prescribe Pregabalin off-label for severe, drug-resistant childhood focal epilepsy when multiple standard anti-seizure medications have failed.
When prescribed by a specialist:
- Weight-based dosing: Doses are calculated strictly in milligrams per kilogram of body weight (mg/kg/day), starting very low and titrating gradually.
- Oral liquid solution: Paediatric patients are prescribed the licensed 20mg/ml oral liquid solution, measured using an accurate calibrated oral syringe.
- Close developmental monitoring: Frequent reviews to assess seizure control, school performance, attention span, and growth.
Emergency action: Accidental child ingestion
Children who ingest adult doses can rapidly experience severe central nervous system depression:
- Profound drowsiness, inability to be woken up, or coma
- Loss of balance, staggering, or falling
- Slow, shallow, or irregular breathing (respiratory depression)
- Sudden seizures, muscle jerks, or vomiting
- Call 999 immediately or take the child to the nearest hospital Emergency Department (A&E).
- Do NOT try to make the child sick: Inducing vomiting in a sedated child risks fatal pulmonary aspiration into the lungs.
- Bring all medication packaging: Hand the blister strips and boxes to the doctors so the hospital can calculate the maximum possible dose ingested.
Child safety in the home: Storing Controlled Drugs
Because Pregabalin is a Class C Controlled Drug with recognized toxicity in children, every patient prescribed Pregabalin must practice strict home safety:
- Store all medication in a high, locked cabinet or lockable medical box out of the reach and sight of children.
- Never leave blister packs on bedside tables, kitchen counters, or inside handbags where curious young children can easily access them.
- Never describe capsules or medicine to children as "sweets" or "candy."
- Return unused or expired Pregabalin to a community pharmacy for safe clinical destruction rather than throwing it in domestic bins.